Latest Organofluorides Stories
The Firm is representing numerous plaintiffs who have filed Risperdal gynecomastia lawsuits in the Pennsylvania litigation. New York, NY (PRWEB) November 05,
European Polytetrafluoroethylene (PTFE) market to reach $603.8 million by 2018 at a CAGR of 5.5% from 2013 to 2018, driven by massive investments from end-user industries of PTFE
The first Risperdal lawsuits trails alleging the anti-psychotic drug caused gynecomastia or enlarged male breasts begin today In Philadelphia. Columbus, OH (PRWEB)
NORTHBROOK, Ill., Nov. 3, 2014 /PRNewswire/ -- Astellas announced today that the U.S.
OTTAWA, Oct. 30, 2014 /CNW Telbec/ - Health Canada today released the October 2014 issue of the Canadian Adverse Reaction Newsletter (CARN).
Launch of Four Novel Immune Checkpoint Inhibitors Will Be the Major Driver of Growth, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct.
Micronized PTFE market report provides a comprehensive review of major market drivers, restraints, opportunities, winning imperatives, challenges, and key issues in the market.(
NEW YORK, Oct.
DALLAS, October 22, 2014 /PRNewswire/ -- RnRMarketResearch.com adds PharmaPoint: HER2-Positive Breast Cancer - Drug Forecast and Market Analysis to 2023 research reports
Many individuals rely on pharmacology for different physical or mental health issues. However, some conditions require certain pharmacology which can be described as used for something entirely different.